Search for author "A. Michael Lincoff"

30 Results

Search Term

Type a term to search within all articles in this journal: e.g., stem cell

Content Type

Journals

Figures (Journals Only)

Select types of content to include in the results.

Citation

Citation-specific search information

Year

e.g., 2009

Volume

e.g., 20

Issue

e.g., 3

First page

e.g., 29

DOI

e.g., 10.9999/123XYZ456

ISBN

Limit Results

Limit search results by date

Include articles in Journal:

Include articles in collection:

Include articles in Table of Contents section:

Include articles in Series

Include Only:

Open Access Articles

Review Articles

Exclude meeting abstracts

Format Results

Number of results per page

Sort

Best Match

Oldest First

Newest First

Format Results

Standard Format

Condensed Format

You have accessRestricted access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial InfarctionPost Hoc Analysis From the CHARISMA Trial
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox and A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes. 2014;7:872-881, originally published September 30, 2014
https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Download PDF
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Figure 1.
A, Absolute standardized differences before and after matching in the (A)...
Show More

A, Absolute standardized differences before and after matching in the (A) prior myocardial infarction cohort, (B) known coronary artery disease cohort, and (C) risk factors alone cohort. ACE indicates angiotensin-converting enzyme; ASA, aspirin; BMI, body mass index; CABG, coronary bypass graft surgery; CCB, calcium channel blockers; DBP, diastolic blood pressure; DM, diabetes mellitus; GP, glycoprotein HTN, hypertension; Hx, history of; PAD, peripheral arterial disease; LMWH, low molecural weight heparin; NSAIDS, nonsteroidal anti-inflammatory agents; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; SC, subcutaneous; and TIA, transient ischemic attack.
Show Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

View table
Table 1.
Baseline Characteristics of the Cohort With Prior Myocardial Infarction Before and After Propensity Score MatchingShow More

Baseline Characteristics of the Cohort With Prior Myocardial Infarction Before and After Propensity Score MatchingShow Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Figure 2.
A, Outcomes in propensity-matched patients on and not on β-blockers in the prior myocardial infarction (MI)...
Show More

A, Outcomes in propensity-matched patients on and not on β-blockers in the prior myocardial infarction (MI) cohort (P values from Cox proportional hazards model). B, Survival free of primary outcome based on β-blocker use status in the prior MI cohort (P values from log-rank test). CI indicates confidence interval; CV, cardiovascular; and HR, hazards ratio.
Show Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

View table
Table 2.
Baseline Characteristics of the Cohort With Known Atherothrombotic Disease Before and After Propensity Score MatchingShow More

Baseline Characteristics of the Cohort With Known Atherothrombotic Disease Before and After Propensity Score MatchingShow Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Figure 3.
Outcomes in propensity-matched patients on and not on β-blockers (BB) in the known coronary artery disease (...
Show More

Outcomes in propensity-matched patients on and not on β-blockers (BB) in the known coronary artery disease (CAD) cohort (P values from Cox proportional hazards model). B, Survival free of primary outcome based on BB use status in the known CAD cohort (P values from log-rank test). CI indicates confidence interval; CV, cardiovascular; and HR, hazards ratio.
Show Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

View table
Table 3.
Baseline Characteristics of the Cohort With Risk Factors Alone Before and After Propensity Score MatchingShow More

Baseline Characteristics of the Cohort With Risk Factors Alone Before and After Propensity Score MatchingShow Less
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Figure 4.
A, Outcomes in propensity-matched patients on and not on β-blockers (BB) in the risk factors alone cohort (...
Show More

A, Outcomes in propensity-matched patients on and not on β-blockers (BB) in the risk factors alone cohort (P values from Cox proportional hazards model). B, Survival free of primary outcome based on BB use status in the risk factors alone cohort (P values from log-rank test). CI indicates confidence interval; CV, cardiovascular; and HR, hazards ratio.
Show Less
You have accessRestricted access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial InfarctionPost Hoc Analysis From the CHARISMA Trial
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox and A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes. 2014;7:872-881, originally published September 30, 2014
https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Download PDF
You have access
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction
Sripal Bangalore, Deepak L. Bhatt, Ph. Gabriel Steg, Michael A. Weber, William E. Boden, Christian W. Hamm, Gilles Montalescot, Amy Hsu, Keith A.A. Fox, A. Michael Lincoff

Circulation: Cardiovascular Quality and Outcomes November 2014, 7 (6) 872-881; DOI: https://doi.org/10.1161/CIRCOUTCOMES.114.001073

Figure 1.
A, Absolute standardized differences before and after matching in the (A)...
Show More

A, Absolute standardized differences before and after matching in the (A) prior myocardial infarction cohort, (B) known coronary artery disease cohort, and (C) risk factors alone cohort. ACE indicates angiotensin-converting enzyme; ASA, aspirin; BMI, body mass index; CABG, coronary bypass graft surgery; CCB, calcium channel blockers; DBP, diastolic blood pressure; DM, diabetes mellitus; GP, glycoprotein HTN, hypertension; Hx, history of; PAD, peripheral arterial disease; LMWH, low molecural weight heparin; NSAIDS, nonsteroidal anti-inflammatory agents; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; SC, subcutaneous; and TIA, transient ischemic attack.
Show Less

Header Publisher Menu

Circulation

Search for author "A. Michael Lincoff"

30 Results

Pages

Selected Facets

Selected Facets

Publication Date

Publication date

Article Type

Article Type

Subject

Subject

Content Type

Resource Type

Customer Service

About Us

Our Sites

Take Action

Online Communities